Axsome Therapeutics, Inc. (AXSM)
253.63
+7.29
(+2.96%)
USD |
NASDAQ |
Jun 11, 16:00
258.00
+4.37
(+1.72%)
After-Hours: 19:17
Axsome Therapeutics Total Liabilities (Quarterly) : 659.02M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 659.02M |
| December 31, 2025 | 601.51M |
| September 30, 2025 | 595.52M |
| June 30, 2025 | 566.71M |
| March 31, 2025 | 543.47M |
| December 31, 2024 | 511.48M |
| September 30, 2024 | 468.56M |
| June 30, 2024 | 445.37M |
| March 31, 2024 | 401.69M |
| December 31, 2023 | 397.26M |
| September 30, 2023 | 331.35M |
| June 30, 2023 | 332.83M |
| March 31, 2023 | 277.37M |
| December 31, 2022 | 221.92M |
| September 30, 2022 | 181.60M |
| June 30, 2022 | 165.36M |
| March 31, 2022 | 73.86M |
| December 31, 2021 | 72.15M |
| September 30, 2021 | 73.88M |
| June 30, 2021 | 71.83M |
| March 31, 2021 | 70.61M |
| Date | Value |
|---|---|
| December 31, 2020 | 72.34M |
| September 30, 2020 | 68.37M |
| June 30, 2020 | 36.75M |
| March 31, 2020 | 41.64M |
| December 31, 2019 | 41.83M |
| September 30, 2019 | 37.62M |
| June 30, 2019 | 30.49M |
| March 31, 2019 | 26.53M |
| December 31, 2018 | 14.44M |
| September 30, 2018 | 15.38M |
| June 30, 2018 | 14.72M |
| March 31, 2018 | 15.35M |
| December 31, 2017 | 18.84M |
| September 30, 2017 | 15.78M |
| June 30, 2017 | 16.29M |
| March 31, 2017 | 17.13M |
| December 31, 2016 | 16.64M |
| September 30, 2016 | 6.736M |
| June 30, 2016 | 5.104M |
| March 31, 2016 | 3.914M |
| December 31, 2015 | 2.632M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 1.341B |
| Filana Therapeutics, Inc. | 40.23M |
| CorMedix, Inc. | 378.59M |
| Eloxx Pharmaceuticals, Inc. | 16.09M |
| Cannabis Global, Inc. | 6.178M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 713.61M |
| Shareholders Equity (Quarterly) | 54.59M |
| Debt to Equity Ratio | 4.028 |
| Current Ratio | 1.392 |
| Net Debt Paydown Yield | -0.04% |